Skip to main content

Day: February 11, 2020

PDS Biotechnology Corporation Announces Pricing of Public Offering of Approximately $12 Million of Shares of Common Stock

PRINCETON, N.J., Feb. 11, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing multiple therapies based on PDS Biotechnology’s proprietary Versamune® T-cell activating technology, today announced the pricing of an underwritten public offering consisting of 9,230,770 shares of common stock at a price to the public of $1.30 per share. The gross proceeds to PDS Biotechnology from this offering are expected to be approximately $12,000,000, before deducting underwriting discounts, commissions and other offering expenses. The offering is expected to close on Friday, February 14, 2020, subject to customary closing conditions.A.G.P./Alliance Global Partners is acting as the sole book-running manager for the offering.A registration statement on Form...

Continue reading

Cross Keys Capital Advises on Mid-Atlantic Retina Practice Affiliation

Ft. Lauderdale, FL, Feb. 11, 2020 (GLOBE NEWSWIRE) — Cross Keys Capital served as the exclusive M&A advisor to The Retina Care Center, LLC (“RCC”) in its affiliation with PRISM Vision Group™. The Retina Care Center is a single-specialty eye care center providing expert management and care for patients with eye problems specific to the retina and vitreous.Led by Eric P. Suan, M.D., Matthew A. Speicher, M.D., Newman J. Sund, M.D., Ph.D., Timothy D. Polk, M.D., and Rohit R. Lakhanpal, M.D., F.A.C.S., The Retina Care Center has been committed to offering patients the most sophisticated and comprehensive diagnostic evaluations and the most current approved treatment for all vitreoretinal disorders since 1998. The team consists of 5 Board-certified, fellowship-trained ophthalmologists and covers 10 locations across Maryland,...

Continue reading

Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner

WINNIPEG, Manitoba, Feb. 11, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX:DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that it has completed its final services milestone under an agreement with its Micro Cultivation partner Because You Cann Inc. (“Because You Cann”).As one of the Company’s micro cultivation partners, Because You Cann entered into a Strategic Cooperation Agreement (“SCA”) with Delta 9 whereby Delta 9 provides services relating to cannabis production facility design and construction, development of standard operating procedures and sanitation programs, consulting on Health Canada licensing, and other services supporting the acquisition of the Health Canada Licence. On February 7, 2020, Because You Cann Inc., confirmed it has reached its final milestone...

Continue reading

DIAGNOS Announces Closing of Private Placement

BROSSARD, Quebec, Feb. 11, 2020 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces that it has completed the non-brokered private placement previously announced on February 5, 2020, of 4,547,110 common shares of the Corporation (each a “Share”) issued at a price of $0.18 per Share, for gross proceeds of $818,479.80 (the “Private placement”).The proceeds from the Private placement will mainly be used to fund sales and marketing as well as administrative expenses.In connection with the Private placement, the Corporation has retained the services of two brokers to act as finders. As per the terms of their engagement agreements, an aggregate cash commission of $63,750.38 was...

Continue reading

Cardinal Energy Ltd. Announces Monthly Dividend for February

CALGARY, Alberta, Feb. 11, 2020 (GLOBE NEWSWIRE) — Cardinal Energy Ltd. (“Cardinal” or the “Company“) (TSX: CJ) confirms that our dividend of $0.015 per common share will be paid on March 16, 2020 to shareholders of record on February 28, 2020. The Board of Directors of Cardinal has declared the dividend payable in cash. This dividend has been designated as an “eligible dividend” for Canadian income tax purposes.About Cardinal Energy Ltd.One of Cardinal’s goals is to continually improve our Environmental, Safety and Governance (“ESG”) mandate and operate our assets in a responsible and environmentally sensitive manner.  As part of this mandate, Cardinal injects and conserves more carbon than it emits making us one of the few Canadian energy companies to have a negative carbon footprint.Cardinal...

Continue reading

Douglas Dynamics, Inc. Announces Fourth Quarter and Full Year 2019 Earnings Release and Conference Call

MILWAUKEE, Feb. 11, 2020 (GLOBE NEWSWIRE) — Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced that it will release financial results for the fourth quarter and full year 2019, after market close on Monday, February 24th, 2020.A conference call will be held to discuss the financial results on Tuesday, February 25th, 2020 at 9:00 a.m. Central Time and will be hosted by Bob McCormick, President and Chief Executive Officer and Sarah Lauber, Chief Financial Officer.The conference call will be simulcast live on the Company’s website at: www.douglasdynamics.com.  Alternatively, please dial (877) 369-6591 domestically, or (253) 237-1176 internationally to join the call.About Douglas DynamicsHome to the most trusted brands in the industry, Douglas...

Continue reading

Toromont Announces 2019 Results and Quarterly Dividend

TORONTO, Feb. 11, 2020 (GLOBE NEWSWIRE) — Toromont Industries Ltd. (TSX: TIH) today reported financial results for the three months and year ended December 31, 2019.“Toromont delivered solid results in the fourth quarter and full year of 2019,” said Scott J. Medhurst, President and Chief Executive Officer of Toromont Industries Ltd. “The Equipment Group recorded growth across its expanded territory.  Reflecting on the substantial acquisition completed in late 2017, we are pleased with our progress to date in integration of operations and the benefits achieved, as we leverage best practices and operational efficiencies. The process is on going.  CIMCO continued to grow its product support business which contributed positively to the bottom line.”Considering the Company’s solid financial position and positive long-term outlook, the...

Continue reading

Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET

HOLLISTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2019 before the market opens on February 26, 2020, and will hold a conference call to discuss the results on February 26, 2020 at 8:00 a.m. Eastern Time.You can access the live conference call by dialing the following phone numbers: toll-free 1 (800) 708-4540 or international 1 (847) 619-6397 and referencing the conference ID # 49371225.The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, log on to http://investor.harvardbioscience.com/ and click on the Earnings Call icon. The webcast will be available on the website through March 4, 2020.Financial information presented on the call, including...

Continue reading

Psychemedics Corporation Announces 4th Quarter and Year-End Results

ACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019.  The Company also announced a quarterly dividend of $0.18 per share payable to shareholders of record as of February 21, 2020 to be paid on March 3, 2020.  This will be the Company’s 94th consecutive quarterly dividend.The Company’s revenue for the year ended December 31, 2019 was $37.7 million versus $42.7 million for the twelve months ended December 31, 2018, a decrease of 12%. Net income for the twelve months ended December 31, 2019 was $1.5 million or $0.28 per diluted share, versus $4.6 million or $0.83 per diluted share, for the comparable period last year, a decrease of 66%.  The Company’s revenue for the quarter ended December 31,...

Continue reading

Clairvest Reports Fiscal 2020 Third Quarter Results

TORONTO, Feb. 11, 2020 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2020 third quarter and nine months ended December 31, 2019. (All figures are in Canadian dollars unless otherwise stated)HighlightsDecember 31, 2019 book value was $863.3 million or $57.19 per share versus $790.3 million or $52.35 per share as at September 30, 2019Net income for the quarter and for the nine months ended December 31, 2019 was $73.0 million or $4.84 per share and $94.4 million or $6.26 per share, respectivelyClairvest and Clairvest Equity Partners V (“CEP V”) completed the sale of their interest in GTA Gaming for cash proceeds of $51.8 millionClairvest and CEP V rolled 100% of their equity interest in Accel Entertainment, Inc. (“Accel Entertainment”) into the business combination of Accel Entertainment and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.